These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20922342)

  • 1. Alzheimer's disease: the strength of association of costs with different measures of disease severity.
    Mauskopf J; Racketa J; Sherrill E
    J Nutr Health Aging; 2010 Oct; 14(8):655-63. PubMed ID: 20922342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
    Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
    J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: results from the GERAS II observational study.
    Olazarán J; Agüera-Ortiz L; Argimón JM; Reed C; Ciudad A; Andrade P; Dilla T
    Int Psychogeriatr; 2017 Dec; 29(12):2081-2093. PubMed ID: 28720158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada.
    Herrmann N; Tam DY; Balshaw R; Sambrook R; Lesnikova N; Lanctôt KL;
    Can J Psychiatry; 2010 Dec; 55(12):768-75. PubMed ID: 21172097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease.
    Reed C; Belger M; Vellas B; Andrews JS; Argimon JM; Bruno G; Dodel R; Jones RW; Wimo A; Haro JM
    Int Psychogeriatr; 2016 Feb; 28(2):247-59. PubMed ID: 26307191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS.
    Reed C; Belger M; Scott Andrews J; Tockhorn-Heidenreich A; Jones RW; Wimo A; Dodel R; Haro JM
    Int Psychogeriatr; 2020 Feb; 32(2):267-277. PubMed ID: 31134870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with Alzheimer's disease living at home in France: costs and consequences of the disease.
    Rigaud AS; Fagnani F; Bayle C; Latour F; Traykov L; Forette F
    J Geriatr Psychiatry Neurol; 2003 Sep; 16(3):140-5. PubMed ID: 12967055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the methods used to estimate the cost of Alzheimer's disease in the United States.
    Mauskopf J; Mucha L
    Am J Alzheimers Dis Other Demen; 2011 Jun; 26(4):298-309. PubMed ID: 21561991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in resource use and costs of dementia care between European countries: baseline data from the ICTUS study.
    Gustavsson A; Jonsson L; Rapp T; Reynish E; Ousset PJ; Andrieu S; Cantet C; Winblad B; Vellas B; Wimo A;
    J Nutr Health Aging; 2010 Oct; 14(8):648-54. PubMed ID: 20922341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.
    Robinson RL; Rentz DM; Andrews JS; Zagar A; Kim Y; Bruemmer V; Schwartz RL; Ye W; Fillit HM
    J Alzheimers Dis; 2020; 75(2):437-450. PubMed ID: 32250304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer's disease: a UK evaluation using discrete-event simulation.
    Getsios D; Blume S; Ishak KJ; Maclaine GD
    Pharmacoeconomics; 2010; 28(5):411-27. PubMed ID: 20402542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials.
    Kahle-Wrobleski K; Fillit H; Kurlander J; Reed C; Belger M
    Eur J Health Econ; 2015 Dec; 16(9):995-1004. PubMed ID: 25410743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study.
    Coduras A; Rabasa I; Frank A; Bermejo-Pareja F; López-Pousa S; López-Arrieta JM; Del Llano J; León T; Rejas J
    J Alzheimers Dis; 2010; 19(2):601-15. PubMed ID: 20110605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.
    Reese JP; Hessmann P; Seeberg G; Henkel D; Hirzmann P; Rieke J; Baum E; Dannhoff F; Müller MJ; Jessen F; Geldsetzer MB; Dodel R
    J Alzheimers Dis; 2011; 27(4):723-36. PubMed ID: 21876256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
    Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
    Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of rivastigmine on costs and on time spent in caregiving for families of patients with Alzheimer's disease.
    Marin D; Amaya K; Casciano R; Puder KL; Casciano J; Chang S; Snyder EH; Cheng I; Cuccia AJ
    Int Psychogeriatr; 2003 Dec; 15(4):385-98. PubMed ID: 15000418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major Cost Drivers in Assessing the Economic Burden of Alzheimer's Disease: A Structured, Rapid Review.
    Kosaner Kließ M; Martins R; Connolly MP
    J Prev Alzheimers Dis; 2021; 8(3):362-370. PubMed ID: 34101795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
    Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
    BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain.
    Darbà J; Kaskens L; Lacey L
    Eur J Health Econ; 2015 Nov; 16(8):895-905. PubMed ID: 25348897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.